Evaluation of routine coagulation testing requirements in patients with severe epistaxis

Basit Öğe Kaydı
dc.contributor.authorÇekmen, Bora
dc.contributor.authorBozan, Öner
dc.contributor.authorAtıs, Seref Emre
dc.contributor.authorÜnver, Sevilay Sema
dc.contributor.authorKokulu, Kamil
dc.contributor.authorKalkan, Asim
dc.date.accessioned2024-09-29T16:31:07Z
dc.date.available2024-09-29T16:31:07Z
dc.date.issued2021
dc.departmentKarabük Üniversitesien_US
dc.description.abstractAim: There are studies about coagulation parameters are not required in the management of epistaxis. The aim of the present study was to investigate whether or not coagulation tests are required and its relationship with medications in severe epistaxis cases that require intervention. Material and Method: The patients above 16 years who had presented to emergency department due to epistaxis, who had undergone anterior/posterior nasal packing or electro-cautery to the nasal mucosa were included the study. The demographic characteristics, blood count, coagulation test, anti-platelet and anti-coagulant medications, the procedures carried out for stopping bleeding, whether reversal treatment or blood transfusion was needed were recorded. Results: A total of 469 patients, it was found that coagulation parameters had been tested in 141(30.2%). While PT, aPTT and INR values of the anti-coagulant using patients were significantly higher(p<0.001, p=0.003, p<0.001, respectively), the platelet and hemoglobin values were not found to be associated with anti-platelet drug and anti-coagulant use(p=0.304, p=0.098, respectively). The patients were allocated to two groups as those any parameter of whom was impaired or not. While a significant difference was found between the groups with regard to hemoglobin values(p=0.006), no patients were determined to need reversal treatment or hemoglobin replacement.Conclusion: Routine coagulation testing is not required for patients who have epistaxis that cannot be stopped with conservative methods and who are using anti-platelet drugs as it does not lead to a difference in treatment. Coagulation tests may not be performed in patients who use anti-coagulants based on the results.en_US
dc.identifier.doi10.37990/medr.904878
dc.identifier.endpage213en_US
dc.identifier.issue3en_US
dc.identifier.startpage210en_US
dc.identifier.trdizinid1125034en_US
dc.identifier.urihttps://doi.org/10.37990/medr.904878
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1125034
dc.identifier.urihttps://hdl.handle.net/20.500.14619/11164
dc.identifier.volume3en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofMedical records-international medical journal (Online)en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleEvaluation of routine coagulation testing requirements in patients with severe epistaxisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu